Skip to main content
HR 4772 106th Congress House Health Administrative procedure Administrative remedies Civil actions and liability Class actions (Civil procedure) Commerce Crime and Law Enforcement Damages Drug industry Economics and Public Finance Fines (Penalties) Government Operations and Politics Injunctions Law Legal fees Prescription pricing Price discrimination Price regulation Punitive damages

Pharmaceutical Products Price Equity Act

Introduced: June 27, 2000 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 106th Congress ended
It never became law before the 106th Congress (1999–2000) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 19, 2000
Referred to the Subcommittee on Health and Environment.
Jun 27, 2000
Referred to the Committee on Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 27, 2000
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service
Pharmaceutical Products Price Equity Act - Directs the President to issue such orders and regulations, and establish such procedures and reporting requirements, as the President determines to be appropriate to ensure that no pharmaceutical product is sold to any consumer in the United States at a price that is more than six percent above the average retail price at which such pharmaceutical product is sold in the five most industrialized, free-market countries, other than the United States. Sets forth enforcement and civil liability provisions. Authorizes appropriations.
What's happening now July 19, 2000

Referred to the Subcommittee on Health and Environment.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 3
 Cosponsors 1
All 1 Democratic 1
D
Norton, Eleanor Holmes
District of Columbia · Sep 26, 2000
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4772: Pharmaceutical Products Price Equity Act. 106th Congress. Open America. https://openamerica.io/bill/106-HR-4772/
MLA
"H.R. 4772: Pharmaceutical Products Price Equity Act." 106th Congress, 2026, Open America, https://openamerica.io/bill/106-HR-4772/.
Bluebook (legal)
H.R. 4772, 106th Cong. (2026), https://openamerica.io/bill/106-HR-4772/.
Markdown link
[H.R. 4772: Pharmaceutical Products Price Equity Act](https://openamerica.io/bill/106-HR-4772/)
Report a problem